REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) Operating cash flow 2019–2025
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$24.6MFY2025 · since FY2019: -$426,591 → -$24.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.6M | +26.7% |
| FY2024 | -$33.5M | -18.4% |
| FY2023 | -$28.3M | -49.4% |
| FY2022 | -$19.0M | -77.7% |
| FY2021 | -$10.7M | -162.3% |
| FY2020 | -$4.1M | -853.3% |
| FY2019 | -$426,591 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RVPH financial trends
RVPH RevenueRVPH Net incomeRVPH Net marginRVPH Gross profitRVPH Gross marginRVPH Operating incomeRVPH Operating marginRVPH Free cash flowRVPH Capital expendituresRVPH Return on equityRVPH Stock buybacksRVPH Dividends paidRVPH Total assetsRVPH Total liabilitiesRVPH Shareholders’ equityRVPH overview →